EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Medical University of Vienna · Zuyderland Medisch Centrum · +57 more institutions
Indexed incrossref
Abstract
No abstract available for this paper.
Citation impact
2,747
total citations
- FWCI
- 356.41
- Percentile
- 100%
- References
- 123
Citations per year
Authors
47- JSJosef S SmolenCorresponding
Medical University of Vienna
- RLRobert Landewé
Zuyderland Medisch Centrum, Amsterdam University Medical Centers
- JWJ. W. J. Bijlsma
University Medical Center Utrecht
- GRGerd R Burmester
Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin
- MDMaxime Dougados
Hôpital Cochin
Topics & keywords
Topics
Keywords
- Medicine
- Antirheumatic drugs
- Rheumatoid arthritis
- Antirheumatic Agents
- Disease management
- Intensive care medicine
- Arthritis
- Disease
No related works found for this paper.